The Study of Prolidase Level and Some Biochemical Variables in Iraqi Patients with Acromegaly
Main Article Content
Abstract
Acromegaly is a condition that results from excessive growth hormone production by the anterior pituitary gland. Prolidase (PLD) is the only known human enzyme that can hydrolyze dipeptides with an amino acid at their C terminus. Reports indicate that PLD activity serves as a marker for oxidative stress in numerous disorders such as diabetes, diabetic neuropathy, chronic liver diseases, and osteoporosis. The current study aims to estimate the values of PLD, its correlation with the rest of the parameters, and ROC in acromegaly patients. A group of 61 patients with confirmed acromegaly were collected from the National Diabetic Center, Mustansyrriah University, and 60 control groups were analyzed in the same place for the parameters of the biochemical study. Acromegalic patients had changes in the levels of biochemical markers like PLD, growth hormone, insulin-like growth factor-1, and fasting blood glucose. There was a high difference (p < 0.001) between the patient group and the healthy control group. The current study shows that PLD levels are higher in patients with acromegaly than in the healthy control group. The sensitivity and specificity for PLD were high in the patient group versus the healthy control. The PLD may be a novel biomarker of acromegaly activity, and there may be an increase in fasting blood glucose, growth hormone, and IGF-1 in acromegaly patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
licenseTerms
Publication Dates
Received
Accepted
Published Online First
References
Wu, T.E; Chen, H.S. The Role of Growth Hormone and IGF-1 in Retinopathy: A Prospective Study of Retinopathy in Patients with Acromegaly and Impaired Fasting Glucose. Diabetology & Metabolic Syndrome 2022, 14(1), 38. https://doi.org/10.1186/s13098-022-00806-z.
Mohammad, T.U. Partial Purification of Leucine aminopeptidase (LAP) in Acromegalic Sample of Iraqi Patients. Journal of Physics 2018, 1003(1), 12-15. https://doi.org/10.1088/1742-6596/1003/1/012015.
Abass, E.A.; Abed, B.A.; Mohsin, S.N. Determination of Osteocalcin, Bone Alkaline Phosphatase, and Lysyl Oxidase in Iraqi Acromegalic Patients. Ibn AL-Haitham Journal for Pure and Applied Sciences 2018, 31(1), 172-179. https://doi.org/10.30526/31.1.1864.
Crisafulli, S.; Fontana, A.; L’Abbate, L.; Ientile,V.; Gianfrilli, D.; Cozzolino, A.; De Martino, M.C.; Ragonese, M.; Sultana, J.; Barone-Adesi, F.; Trifirò, G. Development and Testing of Diagnostic Algorithms to Identify Patients with Acromegaly in Southern Italian Claims Databases. Scientific Reports 2022, 12(1),15843. https://doi.org/10.1038/s41598-022-20295-4.
Hameed, A.S.; Khaleel, F.M.; Rahma, A.M. The Response of Acromegalic Patients (Diabetic Versus Non-Diabetic) to Long-Acting-Repeatable Octreotide (LAR) in the Presence or Absence of Glutathion S Transferase (GSTM1, GSTT1) Genes. Journal of Pharmaceutical Sciences and Research 2019, 11(2), 495-500. https://www.jpsr.pharmainfo.in/Documents/Volumes/vol10Issue12/jpsr10121814.pdf.
Gadelha, M.R.; Kasuki, L.; Lim, D.S.; Fleseriu, M. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocrine Reviews 2019, 40(1), 268-332. https://doi.org/10.1210/er.2018-00115.
Tahir, N.T.; Abdulsattar, S.A.; Alkazzaz, F.F. Assessment of Obesity, Dyslipidemia, Hyperglycemia, and Pro-Inflammatory Cytokines as Cardiovascular Disease Risk Factors in Acromegaly Patients. Baghdad Science Journal 2022, 19(5),0976. http://dx.doi.org/10.21123/bsj.2022.6002.
Hameed, A.S.; Khaleel, F.M.; Rahma, A.M. Superoxide Dismutase and Glutathione S Transferase Enzymes Levels in Diabetic Iraqi Acromegalic Patients. Biochemical and Cellular Archives 2019, 2097-2100. https://doi.org/10.35124/bca.2019.19.S1.2097.
Giustina, A.; Chanson, P.; Kleinberg, D.; Bronstein, M.D.; Clemmons, D.R.; Klibanski, A.; Van Der Lely, A.J.; Strasburger, C.J.; Lamberts, S.W.; Ho, K.K.; Casanueva, F.F. Expert Consensus Document: A Consensus on the Medical Treatment of Acromegaly. Nature Reviews Endocrinology 2014, 10(4), 243-248. https://doi.org/10.1038/nrendo.2014.21.
Tönjes, A.; Quinkler, M.; Knappe, U.; Störmann, S.; Schöfl, C.; Schopohl, J.; Meyhöfer, S.M. Treatment of Acromegaly-Data from the German Acromegaly Register. Deutsche Medizinische Wochenschrift 2023, 148(7), 380-385. https://doi.org/10.1055/a-1847-2553.
Lu, M.; Flanagan, J.U.; Langley, R.J.; Hay, M.P.; Perry, J.K. Targeting Growth Hormone Function: Strategies and Therapeutic Applications. Signal Transduction and Targeted Therapy 2019, 4(1), 3. https://doi.org/10.1038/s41392-019-0036-y.
Ayuk, J.; Sheppard, M.C. Growth Hormone and Its Disorders. Postgraduate Medical Journal 2006, 82(963), 24-30. https://doi.org/10.1136/pgmj.2005.036087.
LeRoith, D.; Yakar, S. Mechanisms of Disease: Metabolic Effects of Growth Hormone and Insulin-Like Growth Factor 1. Nature Clinical Practice Endocrinology & Metabolism 2007, 3(3), 302-310. https://doi.org/10.1038/ncpendmet0427.
Doessing, S.; Holm, L.; Heinemeier, K.M.; Feldt-Rasmussen, U.; Schjerling, P.; Qvortrup, K.; Larsen, J.O.; Nielsen, R.H.; Flyvbjerg, A.; Kjaer, M. GH and IGF1 levels Are Positively Associated with Musculotendinous Collagen Expression: Experiments in Acromegalic and GH Deficiency Patients. European Journal of Endocrinology 2010, 163(6), 853-862. https://doi.org/10.1530/EJE-10-0818.
Tabur, S.; Sezen, H.; Korkmaz, H.; Ozkaya, M.; Akarsu, E. High Prolidase Levels May Be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients?. Experimental and Clinical Endocrinology & Diabetes 2015, 17, 82-6. https://doi.org/10.1055/s-0035-1564200.
Wątor, E.; Rutkiewicz, M.; Weiss, M.S.; Wilk, P. Co‐Expression with Chaperones Can Affect Protein 3d Structure as Exemplified by Loss‐of‐Function Variants of Human Prolidase. FEBS letters 2020, 594(18), 3045-3056. https://doi.org/10.1002/1873-3468.
Abdulrahman, M.A.; Jasim, B.A.; AL-Samaria, A.M.F. The Relationship Between the of Prolidase Activity and Rheumatoid Arthritis. EurAsian Journal of BioSciences 2020, 14(2), 3045.
Spodenkiewicz, M.; Spodenkiewicz, M.; Cleary, M.; Massier, M.; Fitsialos, G.; Cottin , V.; Jouret, G.; Poirsier, C.; Doco-Fenzy, M.; Lèbre, A.S. Clinical Genetics of Prolidase Deficiency: An Updated Review. Biology 2020, 9(5), 108. https://doi.org/10.3390/biology9050108.
Eni-Aganga, I.; Lanaghan, Z.M.; Balasubramaniam, M.; Dash, C.; Pandhare, J.; Prolidase: A Review from Discovery to its Role in Health and Disease. Frontiers in Molecular Biosciences 2021, 8, 723003. https://doi.org/10.3389/fmolb.2021.723003.
Wassenaar, M.J.; Biermasz, N.R.; Van Duinen, N.; Van Der Klaauw, A.A.; Pereira, A.M,; Roelfsema, F.; Smit, J.W.; Kroon, H.M.; Kloppenburg, M.; Romijn, J.A. High Prevalence of Arthropathy, According to the Definitions of Radiological and Clinical Osteoarthritis, in Patients with Long-Term Cure of Acromegaly: European Journal of Endocrinology 2009, 160(3), 357-365. https://doi.org/10.1530/EJE-08-0845.
Giustina, A.; Mazziotti, G.; Canalis, E. Growth Hormone, Insulin-Like Growth Factors, and the Skeleton. Endocrine Reviews 2008, 29(5), 535-559. https://doi.org/10.1210/er.2007-0036.
Doessing, S.; Holm, L.; Heinemeier, K.M.; Feldt-Rasmussen, U.; Schjerling, P.; Qvortrup, K.; Larsen, J.O.; Nielsen, R.H.; Flyvbjerg, A.; Kjaer, M. GH and IGF1 Levels are Positively Associated with Musculotendinous Collagen Expression: Experiments in Acromegalic and GH Deficiency Patients. European Journal of Endocrinology 2010, 163(6), 853-862. https://doi.org/10.1530/EJE-1-0818.
Wassenaar, M.J.; Cazemier, M.; Biermasz, N.R.; Pereira, A.M.; Roelfsema, F.; Smit, J.W.; Hommes, D.W.; Felt-Bersma, R.J.; Romijn, J.A. Acromegaly is Associated with an Increased Prevalence of Colonic Diverticula: A Case-Control Study. The Journal of Clinical Endocrinology & Metabolism 2010, 95(5), 2073-9. https://doi.org/10.1210/jc.2009-1714.
Horoz, M.; Aslan, M.; Bolukbas, F.F.; Bolukbas, C.; Nazligul, Y.; Celik, H.; Aksoy, N. Serum Prolidase Enzyme Activity and its Relation to Histopathological Findings in Patients with Non‐Alcoholic Steatohepatitis. Journal of Clinical Laboratory Analysis 2010, 24(3), 207-211. https://doi.org/10.1002/jcla.20334.
Valkusz, Z.; Tóth, M.; Boda, J.; Nagy, E.; Julesz, J. The Importance of Early Diagnosis of Acromegaly. Orvosi Hetilap 2011, 152(18), 696-702. https://doi.org/10.1556/oh.2011.29109.
Karna, E.; Pałka, J.; Wołczyński, S. Doxycycline-Induced Inhibition of Prolidase Activity in Human Skin Fibroblasts and its Involvement in Impaired Collagen Biosynthesis. European Journal of Pharmacology 2001, 430(1), 25-31. https://doi.org/10.1016/S0014-2999(01)01372-3.
Panahi, Y.; Alishiri, G.H.; Parvin, S.; Sahebkar, A. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis. Journal of Dietary Supplements 2016, 13(2), 209-220. https://doi.org/10.3109/19390211.2015.1008611.
Nishizawa, H.; Handayaningsih, A.E.; Iguchi, G.; Cho, Y.; Takahashi, M.; Yamamoto, M.; Suda, K.; Kasahara, K.; Hakuno, F.; Yamanouchi, K.; Nishihara, M. Enhanced Oxidative Stress in GH-Transgenic Rat and Acromegaly In Humans. Growth Hormone & IGF Research 2012, 22(2), 64-68. https://doi.org/10.3109/19390211.2015.1008611.
Anagnostis, P.; Efstathiadou, Z.A.; Gougoura, S.; Polyzos, S.A.; Karathanasi, E.; Dritsa, P.; Kita, M.; Koukoulis, G.N. Oxidative Stress and Reduced Antioxidative Status, Along with Endothelial Dysfunction in Acromegaly. Hormone and Metabolic Research 2013, 45(04), 314-318. https://doi.org/10.1055/s-0032-1323765.
Claessen, K.M. Ramautar, S.R. Pereira, A.M. Smit, J.W. Roelfsema, F. Romijn, J.A. Kroon, H.M. Kloppenburg, M. Biermasz, N.R. Progression of Acromegalic Arthropathy Despite Long-Term Biochemical Control. European Journal of Endocrinology 2012, 167(2), 235-244. https://doi.org/10.1530/EJE-12-0147.
Claessen, K.M.; Ramautar, S.R.; Pereira, A.M.; Romijn, J.A.; Kroon, H.M.; Kloppenburg, M.; Biermasz, N.R. Increased Clinical Symptoms of Acromegalic Arthropathy in Patients with Long-Term Disease Control: A Prospective Follow-Up Study. Pituitary 2014, 17, 44-52.